Coronary angiography is the gold standard for evaluating coronary atherosclerotic heart disease, yet it has well-known limitations. Intravascular ultrasound (IVUS) is an invasive technique that is used to improve the assessment and management of coronary artery disease. IVUS is a readily available imaging modality that is easy to learn and interpret with low complication rates. In this literature review, the authors will review the technique and discuss the various current usages of IVUS and its limitations, safety, and complications.
AgostoniP.ValgimigliM.Van MieghemC. A.Rodriguez-GranilloG. A.AokiJ.OngA. T.. . . SerruysP. W. (2005). Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. American Journal of Cardiology, 95, 644-647.
2.
ArnettE. N.IsnerJ. M.RedwoodD. R.KentK. M.BakerW. P.AckersteinH.RobertsW. C. (1979). Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necropsy findings. Annals of Internal Medicine, 91, 350-356.
3.
BatkoffB. W.LinkerD. T. (1996). Safety of intracoronary ultrasound: Data from a multicenter European registry. Catheterization and Cardiovascular Diagnosis, 38, 238-241.
4.
BrownB. G.ZhaoX. Q. (2007). Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?Journal of the American College of Cardiology, 49, 933-938.
5.
CheneauE.LeborgneL.MintzG. S.KotaniJ.PichardA. D.SatlerL. F.. . . WaksmanR. (2003). Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation, 108, 43-47.
6.
CutlipD. E.WindeckerS.MehranR.BoamA.CohenD. J.van EsG. A.. . . SerruysP. W. (2007). Clinical end points in coronary stent trials: A case for standardized definitions. Circulation, 115, 2344-2351.
7.
FitzgeraldP. J.OshimaA.HayaseM.MetzJ. A.BaileyS. R.BaimD. S.. . . YockP. G. (2000). Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation, 102, 523-530.
8.
GalbraithJ. E.MurphyM. L.de SoyzaN. (1978). Coronary angiogram interpretation. Interobserver variability. Journal of the American Medical Association, 240, 2053-2056.
9.
GlagovS.WeisenbergE.ZarinsC. K.StankunaviciusR.KolettisG. J.. Compensatory enlargement of human atherosclerotic coronary arteries. (1987). New England Journal of Medicine, 316, 1371-1375.
10.
GrondinC. M.DyrdaI.PasternacA.CampeauL.BourassaG.LesperanceJ. (1974). Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation, 49, 703-708.
11.
GuedesA.KellerP. F.L’AllierP. L.LesperanceJ.GregoireJ.TardiffJ. C. (2005). Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. Journal of the American College of Cardiology, 45, 559-564.
12.
HausmannD.ErbelR.Alibelli-ChemarinM. J.BokschW.CaraccioloE.CohnJ. M.. . . DiMarioC. (1995). The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation, 91, 623-630.
13.
HongM. K.MintzG. S.LeeC. W.ParkD. W.ChoiB. R.ParkK. H.. . . ParkS. J. (2006). Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. European Heart Journal, 27, 1305-1310.
14.
JaffeR.StraussB. H. (2007). Late and very late thrombosis of drug-eluting stents: Evolving concepts and perspectives. Journal of the American College of Cardiology, 50, 119-127.
15.
KawaguchiR.SabateM.AngiolilloD. J.Jimenez-QuevedoP.SuzukiN.CorrosC.. . . CostaM. A. (2008). Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. International Journal of Cardiovascular Imaging, 24, 125-132.
16.
MintzG. S.MaeharaA. (2009). Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations. Circulation Journal, 73, 1557-1560.
17.
MintzG. S.PainterJ. A.PichardA. D.KentK. M.SatlerL. F.PopmaJ. J.. . . LeonM. B. (1995). Atherosclerosis in angiographically “normal” coronary artery reference segments: An intravascular ultrasound study with clinical correlations. Journal of the American College of Cardiology, 25, 1479-1485.
18.
MiyazawaA.AkoJ.HongoY.HurS. H.TsujinoI.CourtneyB. K.. . . FitzgeraldP. J. (2008). Comparison of vascular response to zotarolimus-eluting stent vs. sirolimus-eluting stent: IVUS results from ENDEAVOR III. American Heart Journal, 155, 108-113.
19.
MosesJ. W.LeonM. B.PopmaJ. J.FitzgeraldP. J.HolmesD. R.O’ShaughnessyC.. . . KuntzR. E. (2003). Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery. New England Journal of Medicine, 349, 1315-1323.
20.
MudraH.di MarioC.de JaegereP.FigullaH. R.MacayaC.ZahnR.. . . ZeiherA. (2001). Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS study). Circulation, 104, 1343-1349.
21.
NakamuraT.ChenJ. P.PanchalD.NguyenT.KingS. B.ChronosN.HouD. (2010). The role of intravascular ultrasound to guide drug-eluting stents implantation. Cardiovascular & Hematological Agents in Medicinal Chemistry, 8, 22-28.
22.
NissenS. E. (2002). Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. American Journal of Cardiology, 89, 24B-31B.
23.
NissenS. E.YockP. (2001). Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation, 103, 604-616.
24.
NissenS. E.GurleyJ. C.GrinesC. L.BoothD. C.McLureR.BerkM.. . . DeMariaA. N. (1991). Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation, 84, 1087-1099.
25.
NissenS. E.NichollsS. J.SipahiI.LibbyP.RaichlenJ. S.BallantyneC. M.. . . TuzcuE. M. (2006). Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. Journal of the American Medical Association, 295, 1556-1565.
26.
NissenS. E.TuzcuE. M.LibbyP.ThompsonP. D.GhaliM.GarzaD.. . . TopolE. J. (2004). Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial. Journal of the American Medical Association, 292, 2217-2225.
27.
PorterT. R.SearsT.XieF.MichelsA.MataJ.WelshD.ShurmurS. (1993). Intravascular ultrasound study of angiographically mildly diseased coronary arteries. Journal of the American College of Cardiology, 22, 1858-1865.
28.
RoyP.SteinbergD. H.SushinskyS. J.OkabeT.Pinto SlottowT. L.KaneshigeK.. . . WaksmanR. (2008). The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. European Heart Journal, 29, 1851-1857.
29.
SakuraiR.AkoJ.MorinoY.SonodaS.KanedaH.TerashimaM.. . . HondaY. (2005). Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). American Journal of Cardiology, 96, 1251-1253.
30.
SerruysP. W.DegertekinM.TanabeK.AbizaidA.SousaJ. E.ColomboA.. . . MoriceM. C. (2002). Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimuseluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation, 106, 798-803.
31.
SheibanI.VillataG.BollatiM.SillanoD.LotrionteM.Biondi-ZoccaiG. (2008). Next-generation drug-eluting stents in coronary artery disease: Focus on everolimus-eluting stent (Xience V). Vascular Health and Risk Management, 4, 31-38.
32.
SipahiI.TuzcuE. M.SchoenhagenP.NichollsS. J.OzduranV.KapadiaS.NissenS. E. (2006). Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: Serial intravascular ultrasound observations from the REVERSAL trial. European Heart Journal, 27, 1664-1670.
33.
TanabeK.SerruysP. W.DegertekinM.GuagliumiG.GrubeE.ChanC.. . . ColomboA. (2004). Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: Comparison with bare metal stents by serial intravascular ultrasound analyses: Data from the randomized TAXUS-II trial. Circulation, 109, 196-200.
34.
TobisJ. M.MalleryJ.MahonD.LehmannK.ZaleskyP.GriffithJ.. . . DwyerM. L. (1991). Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation, 83, 913-926.
35.
TopolE. J.NissenS. E. (1995). Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation, 92, 2333-2342.
36.
von BirgelenC.HartmannM.MintzG. S.van HouwelingenK. G.DeppermannN.SchmermundA.. . . ErbelR. (2004). Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation, 110, 1579-1585.
37.
WeissmanN. J.KoglinJ.CoxD. A.HermillerJ.O’ShaughnessyC.MannJ. T.. . . StoneG. W. (2005). Polymer-based paclitaxeleluting stents reduce in-stent neointimal tissue proliferation: A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. Journal of the American College of Cardiology, 45, 1201-1205.
38.
YamadaK. P.KoizumiT.YamaguchiH.KanedaH.BonneauH. N.HondaY.FitzgeraldP. J. (2008). Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. International Journal of Cardiology, 130, 255-259.
39.
YehyaA.MandawatM. K. (2011). Fractional flow reserve: A review for cardiac catherization lab personnel. Cardiac Cath Lab Director. Advance online publication. doi: 10.1177/2150133511399755
